BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17549036)

  • 1. Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice.
    Abu-Fanne R; Brzezinski A; Golomb M; Grad E; Foldes AJ; Shufaro Y; Varon D; Brill A; Lotan C; Danenberg HD
    Menopause; 2008; 15(1):98-104. PubMed ID: 17549036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.
    Okano H; Jayachandran M; Yoshikawa A; Miller VM
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):621-8. PubMed ID: 16680078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
    Iwakura A; Luedemann C; Shastry S; Hanley A; Kearney M; Aikawa R; Isner JM; Asahara T; Losordo DW
    Circulation; 2003 Dec; 108(25):3115-21. PubMed ID: 14676142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats.
    Chung MT; Cheng PY; Lam KK; Chen SY; Ting YF; Yen MH; Lee YM
    Menopause; 2010; 17(1):127-34. PubMed ID: 19745773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats.
    Ammann P; Bourrin S; Brunner F; Meyer JM; Clément-Lacroix P; Baron R; Gaillard M; Rizzoli R
    Bone; 2004 Jul; 35(1):153-61. PubMed ID: 15207751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene.
    Helvering LM; Liu R; Kulkarni NH; Wei T; Chen P; Huang S; Lawrence F; Halladay DL; Miles RR; Ambrose EM; Sato M; Ma YL; Frolik CA; Dow ER; Bryant HU; Onyia JE
    Mol Pharmacol; 2005 Nov; 68(5):1225-38. PubMed ID: 16079270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo.
    Nemcsik J; Morschl E; Egresits J; Kordás K; László F; László FA; Pávó I
    Eur J Pharmacol; 2004 Jul; 495(2-3):179-84. PubMed ID: 15249168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
    Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
    Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of 17beta-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins.
    Rzewuska-Lech E; Jayachandran M; Fitzpatrick LA; Miller VM
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E105-12. PubMed ID: 15713688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
    Jochems C; Islander U; Kallkopf A; Lagerquist M; Ohlsson C; Carlsten H
    Arthritis Rheum; 2007 Oct; 56(10):3261-70. PubMed ID: 17907171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with raloxifene and 17beta-estradiol differentially modulates nitric oxide and prostanoids in venous endothelium and platelets of ovariectomized pigs.
    Lewis DA; Avsar M; Labreche P; Bracamonte M; Jayachandran M; Miller VM
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):231-8. PubMed ID: 17110805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.
    Stovall DW; Utian WH; Gass ML; Qu Y; Muram D; Wong M; Plouffe L
    Menopause; 2007; 14(3 Pt 1):510-7. PubMed ID: 17314736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
    Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
    Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene effects on thyroid gland morphology in ovariectomized rats.
    de Araujo LF; Grozovsky R; de Campos Pinheiro M; de Carvalho JJ; Vaisman M; Carvalho DP
    Fertil Steril; 2008 Oct; 90(4):1211-4. PubMed ID: 18178201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activation of gene transcription via oestrogen response elements by a raloxifene analogue.
    Engdahl C; Jochems C; Gustafsson JA; van der Saag PT; Carlsten H; Lagerquist MK
    J Endocrinol; 2009 Dec; 203(3):349-56. PubMed ID: 19752149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.
    de Araujo LF; Grozovsky R; dos Santos Pereira MJ; de Carvalho JJ; Vaisman M; Carvalho DP
    Thyroid; 2010 Jan; 20(1):85-92. PubMed ID: 20017619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.